Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TKBMN, LLC is a medical technology and intellectual property holding company based in Indiana that specializes in the development of neuromodulation therapies. The company holds the foundational patents for Percutaneous Electrical Nerve Field Stimulation (PENFS), a non-invasive electro-therapy technology designed to modulate central pain pathways. This technology is exclusively licensed to Neuraxis, Inc. (formerly Innovative Health Solutions) for the development and commercialization of the IB-Stim device. IB-Stim is an FDA-cleared, non-surgical treatment for functional abdominal pain associated with irritable bowel syndrome (IBS) in pediatric patients. TKBMN is closely integrated with Neuraxis through shared leadership, with members of the Carrico family serving as key executives and inventors for both entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TKBMN.